Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosiglitazone to reduce fatty liver in liver transplant recipients with type 2 diabetes
2005-004253-10Phase 4Completed
- Sponsor
- Helena Isoniemi
- Start
- Apr 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of rosiglitazone in steatosis and type 2 diabetes mellitus (T2DM), sponsored by Helena Isoniemi. Started Apr 2006; status: completed.
02
Drugs
rosiglitazone
03
Conditions
steatosistype 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2005-004253-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004253-10.